Sanford, FL, United States of America

Umasudhan Palaniswamy

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: U.S. Nutraceuticals, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Umasudhan Palaniswamy. Retrieved from https://idiyas.com/inventor/umasudhan-palaniswamy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Umasudhan Palaniswamy: Innovator in Nutraceuticals

Introduction: Umasudhan Palaniswamy is an inventor based in Sanford, FL (US). He is associated with U.S. Nutraceuticals, Inc., doing business as Valensa International. Although he currently holds no granted patents, his work in the field of dietary supplements is noteworthy.

Latest Patent Applications: Umasudhan has been involved in several patent applications, including a significant one titled "Dietary Supplement Composition Having Enhanced LSESr and Method of Making." This application describes a dietary supplement composition that includes a shelf-stable, supercritical CO2 fluid-extracted, enhanced lipidosterolic extract (LSESr). The composition boasts an enrichment of lauric, myristic, oleic, and linoleic free fatty acids, with total free fatty acids greater than about 82.0%. The method of making this enhanced LSESr involves subjecting aged saw palmetto powder to supercritical CO2 extraction followed by first and second separations. Another application with a similar title also emphasizes the enrichment of free fatty acids, achieving a ratio greater than about 83.0%.

Conclusion: Umasudhan Palaniswamy is making strides in the nutraceutical industry through his innovative approaches to dietary supplements. His latest patent applications reflect his commitment to enhancing health through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…